Mutations in the CARD11 gene, which is known to be recurrently targeted in DLBCL and in splenic marginal zone lymphomas [28, 29], were discovered in three tumor samples derived from two patients. The gene discussed is CARD11; the disease is diffuse large B-cell lymphoma.